PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome

Kenjiro Kosaki, Taichi Suzuki, Koji Muroya, Tomonobu Hasegawa, Seiji Sato, Nobutake Matsuo, Rika Kosaki, Toshiro Nagai, Yukihiro Hasegawa, Tsutomu Ogata

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Noonan syndrome is an autosomal dominant disorder defined by short stature, delayed puberty, and characteristic dysmorphic features. Tartaglia et al. (Nature Genetics, 29:465-468) have recently shown that gain-of-function mutations in the gene PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) cause Noonan syndrome in roughly haft of patients that they examined. To further explore the relevance of PTPN11 mutations to the pathogenesis of Noonan syndrome, we analyzed the PTPN11 gene in 21 Japanese patients. Mutation analysis of the 15 coding exons and their flanking introns by denaturing HPLC and direct sequencing revealed six different heterozygous missense mutations (Asp61Gly, Tyr63Cys, Ala72Ser, Thr73Ile, Phe285Ser, and Asn308Asp) in seven cases (six sporadic and one familial). The mutations clustered either in the N-Src homology 2 domain or in the protein-tyrosine phosphatase domain. The clinical features of the mutation-positive and mutation-negative patients were comparable. The results provide further support to the notion that PTPN11 mutations are responsible for the development of Noonan syndrome in a substantial fraction of patients and that relatively infrequent features of Noonan syndrome, such as sensory deafness and bleeding diathesis, can also sresult from mutations of PTPN11.

Original languageEnglish
Pages (from-to)3529-3533
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume87
Issue number8
DOIs
Publication statusPublished - 2002

Fingerprint

Noonan Syndrome
Protein Tyrosine Phosphatases
Mutation
Delayed Puberty
Introns
src Homology Domains
Exons
Disease Susceptibility
Deafness
Missense Mutation
Genes
High Pressure Liquid Chromatography
Hemorrhage

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome. / Kosaki, Kenjiro; Suzuki, Taichi; Muroya, Koji; Hasegawa, Tomonobu; Sato, Seiji; Matsuo, Nobutake; Kosaki, Rika; Nagai, Toshiro; Hasegawa, Yukihiro; Ogata, Tsutomu.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 87, No. 8, 2002, p. 3529-3533.

Research output: Contribution to journalArticle

Kosaki, Kenjiro ; Suzuki, Taichi ; Muroya, Koji ; Hasegawa, Tomonobu ; Sato, Seiji ; Matsuo, Nobutake ; Kosaki, Rika ; Nagai, Toshiro ; Hasegawa, Yukihiro ; Ogata, Tsutomu. / PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome. In: Journal of Clinical Endocrinology and Metabolism. 2002 ; Vol. 87, No. 8. pp. 3529-3533.
@article{2f8722e0700f44cdb70cb1e459aaf789,
title = "PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome",
abstract = "Noonan syndrome is an autosomal dominant disorder defined by short stature, delayed puberty, and characteristic dysmorphic features. Tartaglia et al. (Nature Genetics, 29:465-468) have recently shown that gain-of-function mutations in the gene PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) cause Noonan syndrome in roughly haft of patients that they examined. To further explore the relevance of PTPN11 mutations to the pathogenesis of Noonan syndrome, we analyzed the PTPN11 gene in 21 Japanese patients. Mutation analysis of the 15 coding exons and their flanking introns by denaturing HPLC and direct sequencing revealed six different heterozygous missense mutations (Asp61Gly, Tyr63Cys, Ala72Ser, Thr73Ile, Phe285Ser, and Asn308Asp) in seven cases (six sporadic and one familial). The mutations clustered either in the N-Src homology 2 domain or in the protein-tyrosine phosphatase domain. The clinical features of the mutation-positive and mutation-negative patients were comparable. The results provide further support to the notion that PTPN11 mutations are responsible for the development of Noonan syndrome in a substantial fraction of patients and that relatively infrequent features of Noonan syndrome, such as sensory deafness and bleeding diathesis, can also sresult from mutations of PTPN11.",
author = "Kenjiro Kosaki and Taichi Suzuki and Koji Muroya and Tomonobu Hasegawa and Seiji Sato and Nobutake Matsuo and Rika Kosaki and Toshiro Nagai and Yukihiro Hasegawa and Tsutomu Ogata",
year = "2002",
doi = "10.1210/jc.87.8.3529",
language = "English",
volume = "87",
pages = "3529--3533",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "8",

}

TY - JOUR

T1 - PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome

AU - Kosaki, Kenjiro

AU - Suzuki, Taichi

AU - Muroya, Koji

AU - Hasegawa, Tomonobu

AU - Sato, Seiji

AU - Matsuo, Nobutake

AU - Kosaki, Rika

AU - Nagai, Toshiro

AU - Hasegawa, Yukihiro

AU - Ogata, Tsutomu

PY - 2002

Y1 - 2002

N2 - Noonan syndrome is an autosomal dominant disorder defined by short stature, delayed puberty, and characteristic dysmorphic features. Tartaglia et al. (Nature Genetics, 29:465-468) have recently shown that gain-of-function mutations in the gene PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) cause Noonan syndrome in roughly haft of patients that they examined. To further explore the relevance of PTPN11 mutations to the pathogenesis of Noonan syndrome, we analyzed the PTPN11 gene in 21 Japanese patients. Mutation analysis of the 15 coding exons and their flanking introns by denaturing HPLC and direct sequencing revealed six different heterozygous missense mutations (Asp61Gly, Tyr63Cys, Ala72Ser, Thr73Ile, Phe285Ser, and Asn308Asp) in seven cases (six sporadic and one familial). The mutations clustered either in the N-Src homology 2 domain or in the protein-tyrosine phosphatase domain. The clinical features of the mutation-positive and mutation-negative patients were comparable. The results provide further support to the notion that PTPN11 mutations are responsible for the development of Noonan syndrome in a substantial fraction of patients and that relatively infrequent features of Noonan syndrome, such as sensory deafness and bleeding diathesis, can also sresult from mutations of PTPN11.

AB - Noonan syndrome is an autosomal dominant disorder defined by short stature, delayed puberty, and characteristic dysmorphic features. Tartaglia et al. (Nature Genetics, 29:465-468) have recently shown that gain-of-function mutations in the gene PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) cause Noonan syndrome in roughly haft of patients that they examined. To further explore the relevance of PTPN11 mutations to the pathogenesis of Noonan syndrome, we analyzed the PTPN11 gene in 21 Japanese patients. Mutation analysis of the 15 coding exons and their flanking introns by denaturing HPLC and direct sequencing revealed six different heterozygous missense mutations (Asp61Gly, Tyr63Cys, Ala72Ser, Thr73Ile, Phe285Ser, and Asn308Asp) in seven cases (six sporadic and one familial). The mutations clustered either in the N-Src homology 2 domain or in the protein-tyrosine phosphatase domain. The clinical features of the mutation-positive and mutation-negative patients were comparable. The results provide further support to the notion that PTPN11 mutations are responsible for the development of Noonan syndrome in a substantial fraction of patients and that relatively infrequent features of Noonan syndrome, such as sensory deafness and bleeding diathesis, can also sresult from mutations of PTPN11.

UR - http://www.scopus.com/inward/record.url?scp=18544388673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18544388673&partnerID=8YFLogxK

U2 - 10.1210/jc.87.8.3529

DO - 10.1210/jc.87.8.3529

M3 - Article

C2 - 12161469

AN - SCOPUS:18544388673

VL - 87

SP - 3529

EP - 3533

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 8

ER -